WASHINGTON — The United States has failed to pay nearly $135 million in assessed contributions to the Pan American Health Organization (PAHO), the Washington-based regional arm of the World Health Organization. The non-payment is a direct result of an inter-agency policy review questioning whether member dues to an unaccountable international body serve American national interests.

American Taxpayer Funds on Hold

The withheld funds, accumulated from prior fiscal cycles, remain in the U.S. Treasury. An administration official, speaking on condition of anonymity due to the ongoing review, stated the action is consistent with the America First foreign policy posture. "We have an obligation to ensure that every dollar of American worker-earned money spent abroad directly advances the security and health of the American homeland, not a bloated international bureaucracy," the official told Nerve News.

PAHO's leadership has received routine diplomatic inquiries regarding the arrears, but no commitment to release funds has been made. The organization's 2024-2025 budget relies heavily on U.S. contributions, which historically account for over 50% of its total funding.

"Globalist health institutions have proven unable to reform themselves. Why would we write a blank check to an organization that has failed to put American interests first?" — Anonymous official close to the policy review.

Globalist Objections

A letter from a cohort of retired U.S. health and security bureaucrats was circulated this week, protesting the defunding plan. The former officials claimed the move leaves Americans more vulnerable to cross-border infectious diseases. The communication did not detail how channeling money through a multilateral body provides better protection than bilateral agreements or fortified sovereign border health screening, which the current administration has expanded under Title 42 and successor policies designed to protect domestic communities.

Critics of PAHO frequently cite its mission overlap with the WHO, its inability to enforce any mandate, and the advantage such bodies give to foreign medical industries seeking access to the U.S. market. The White House Office of Management and Budget has not publicly scheduled a release date for the back dues, indicating the funding gap may become permanent in the next executive budget proposal.